| Joel Matthew Bradley, MD | |
|
1 Medical Center Dr, Dartmouth Hitchcock - Pediatrics, Lebanon, NH 03756-1000 | |
| (603) 653-6063 | |
| Not Available |
| Full Name | Joel Matthew Bradley |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1 Medical Center Dr, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164782850 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 17489 (New Hampshire) | Primary |
| 207R00000X | Internal Medicine | EC121077 (Maine) | Secondary |
| Entity Name | Mary Hitchcock Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023092053 PECOS PAC ID: 4486561164 Enrollment ID: O20031126000258 |
News Archive
A new laser therapy that can potentially remove cataracts from people's eyes more efficiently and with greater precision was presented on October 24, 2009 at the American Academy of Ophthalmology (AAO) annual meeting.
The study, published today in The Lancet's eBioMedicine, by King's College London in collaboration with University of Trieste and the International Centre for Genetic Engineering and Biology in Italy, shows the unique characteristics to the SARS-CoV-2 virus and may explain why patients suffer from 'long COVID'.
Harvard Stem Cell Institute researchers at Harvard University and the Broad Institute of Harvard and MIT have found evidence that bone marrow transplantation may one day be beneficial to a subset of patients suffering from amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder more commonly known as Lou Gehrig's disease.
NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today financial results for the quarter ended March 31, 2010.
In 2009 the Patents Court of the High Court, Chancery Division, decided that Occlutech's range of Figulla ASD and PFO occluders do not infringe the U.K. part of European Patent 0 808 138. AGA Medical decided to appeal against this decision. The U.K. Court of Appeal (civil division) in London announced its decision confirming that said Figulla ASD and PFO occluders do not infringe said patent.
› Verified 4 days ago
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
A new laser therapy that can potentially remove cataracts from people's eyes more efficiently and with greater precision was presented on October 24, 2009 at the American Academy of Ophthalmology (AAO) annual meeting.
The study, published today in The Lancet's eBioMedicine, by King's College London in collaboration with University of Trieste and the International Centre for Genetic Engineering and Biology in Italy, shows the unique characteristics to the SARS-CoV-2 virus and may explain why patients suffer from 'long COVID'.
Harvard Stem Cell Institute researchers at Harvard University and the Broad Institute of Harvard and MIT have found evidence that bone marrow transplantation may one day be beneficial to a subset of patients suffering from amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder more commonly known as Lou Gehrig's disease.
NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today financial results for the quarter ended March 31, 2010.
In 2009 the Patents Court of the High Court, Chancery Division, decided that Occlutech's range of Figulla ASD and PFO occluders do not infringe the U.K. part of European Patent 0 808 138. AGA Medical decided to appeal against this decision. The U.K. Court of Appeal (civil division) in London announced its decision confirming that said Figulla ASD and PFO occluders do not infringe said patent.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joel Matthew Bradley, MD 1 Medical Center Dr, Dartmouth Hitchcock - Pediatrics, Lebanon, NH 03756-1000 Ph: (603) 653-6063 | Joel Matthew Bradley, MD 1 Medical Center Dr, Dartmouth Hitchcock - Pediatrics, Lebanon, NH 03756-1000 Ph: (603) 653-6063 |
News Archive
A new laser therapy that can potentially remove cataracts from people's eyes more efficiently and with greater precision was presented on October 24, 2009 at the American Academy of Ophthalmology (AAO) annual meeting.
The study, published today in The Lancet's eBioMedicine, by King's College London in collaboration with University of Trieste and the International Centre for Genetic Engineering and Biology in Italy, shows the unique characteristics to the SARS-CoV-2 virus and may explain why patients suffer from 'long COVID'.
Harvard Stem Cell Institute researchers at Harvard University and the Broad Institute of Harvard and MIT have found evidence that bone marrow transplantation may one day be beneficial to a subset of patients suffering from amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder more commonly known as Lou Gehrig's disease.
NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today financial results for the quarter ended March 31, 2010.
In 2009 the Patents Court of the High Court, Chancery Division, decided that Occlutech's range of Figulla ASD and PFO occluders do not infringe the U.K. part of European Patent 0 808 138. AGA Medical decided to appeal against this decision. The U.K. Court of Appeal (civil division) in London announced its decision confirming that said Figulla ASD and PFO occluders do not infringe said patent.
› Verified 4 days ago
Sheila L Feyrer, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5 Alice Peck Day Dr, Lebanon, NH 03766 Phone: 603-448-3122 Fax: 603-448-7491 | |
Scott Shipman, MD, MPH Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-653-9337 | |
Dr. Julie Lucy Sanville, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: One Medical Center Drive, Gastroenterology, Lebanon, NH 03756 Phone: 603-653-9666 Fax: 603-653-9166 | |
Dr. Torunn Thorsen Rhodes, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-653-6063 | |
Kimberly Molina, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Dr. Tricia Lynn Groff, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Dhmc Department Of Pediatrics, Lebanon, NH 03756 Phone: 603-653-9663 | |
Paul Eric Palumbo, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Infectious Disease - Dartmouth-hitchcock Med Ctr, Lebanon, NH 03756 Phone: 603-650-8840 Fax: 603-650-6199 |